Infectious Disease
HHS announces savings on 43 prescription drugs for Medicare Part B beneficiaries
Source/Disclosures
Disclosures:
Becerra and Brooks-LaSure reports no relevant financial disclosures.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio
Key takeaways:
- Medicare Part B beneficiaries may pay lower coinsurance on 43 drugs that had prices rise faster than the rate of inflation in a benchmark quarter.
- The drugs include acetaminophen, nitroglycerin and more.
HHS has released a list of 43 prescription drugs for which Part B beneficiary coinsurances may be lower starting July 1.
“The Medicare Prescription Drug Inflation Rebate Program is a critical way to address long-term price increases by drug companies, and CMS is continuing our work to make prescription drugs more affordable for people with Medicare,” CMS Administrator Chiquita Brooks-LaSure said in a press release. “CMS is working tirelessly to ensure timely implementation of the Inflation Reduction Act to strengthen Medicare now and in the future.”
HHS has released a list of 43 prescription drugs for which Part B beneficiary coinsurances may be lower for several months this year. Source: Adobe Stock
Because of the Inflation Reduction Act, people with Medicare could pay a lower coinsurance for some Part B drugs if their price increases faster than the rate of inflation, according to the release. So, if this happens, HHS Secretary Xavier Becerra said in a press release that manufacturers of qualifying drugs must pay rebates to Medicare.
“And, Medicare now has the authority to negotiate lower prescription drug prices for the first time,” Becerra said.
Some people who have Medicare Part B could pay lower coinsurance on 43 drugs that had prices rise faster than the rate of inflation in a benchmark quarter. Depending on their individual coverage, people who take these drugs may save between $1 and $449 per average dose between July 1 and Sept. 30. The drugs are as follows:
- acetaminophen (Hikma);
- alfentanil hcl, 500 mcg;
- allopurinol sodium, 1 mg;
- amnioband, 1 mg;
- bendamustine, 1 mg;
- bendamustine, 1 mg (Baxter);
- biorphene, 20 micrograms;
- bupivacaine, nos, 0.5 mg;
- cefiderocol, 10 mg;
- ciltacabtagene;
- cimerli, 0.1 mg;
- clindamycin phosphate, 300 mg;
- cytal, per square centimeter;
- dermagraft (organogenesis);
- eflapegrastim-xnst, 0.1 mg;
- elahere, 1 mg;
- epinephrines (belcher);
- esmolol hydrochloride, 10mg;
- esmolol hydrochloride (WG Critical Care);
- Fiasp for insulin pump use (Novo Nordisk);
- heparin, 1,000u (Pfizer);
- hmatrix;
- interfyl, 1 mg;
- invega hafyera/trinza;
- Ixinity, 1 iu (Medexus Pharma, Inc);
- labetalol hydrochloride, 5mg;
- labetalol hydrochloride, 5mg (Hikma);
- leuprolide depot 7.5mg (Cipla);
- lisocabtagene maraleucel;
- Lyumjev for insulin pump use (Eli Lilly & Co.);
- metronidazole, 10 mg;
- naxitamab-gqgk, 1mg;
- nitroglycerin, 5 mg;
- palingen or palingen xplus;
- panzyga, 500 mg;
- plasminogen tvmh, 1 mg;
- repriza, 1 cm;
- teclistamab cqyv, 0.5 mg;
- teplizumab mzwv, 5 mcg;
- tremelimumab-actl, 1 mg;
- vasopressin (am reg) 1 u; other
- vasopressin, 1 unit.
The HHS announcement came days after Merck sued the federal government over the plan to negotiate Medicare drug prices.
In a complaint filed June 6, the drugmaker said that the program, which was laid out in the Inflation Reduction Act, does not involve genuine negotiation, but rather that the HHS chooses drugs to be included and then names the price. The complaint said it is “tantamount to extortion” and violates the Constitution.
References:
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Back to Healio